|
This is a medication treatment study for adults with Body Dysmorphic Disorder in collaboration with Butler Hospital that seeks to establish the efficacy of Escitalopram, also known as Lexapro, in the treatment of this disorder. Additionally, this study seeks to determine whether individuals who do well on Escitalopram will continue to do well after discontinuation of the medication. It is hoped that some of the gains made during medication treatment can be maintained after the treatment has ceased. Lexapro is among the most highly recommended medications for BDD, although there is currently no FDA approved medication for BDD. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This study seeks to investigate the effectiveness of Fluoxetine as a treatment for children and adolescents with Body Dysmorphic Disorder. Information we have so far suggests that Fluoxetine, also marketed as Prozac, might prove effective in treating the effects of this potentially devastating disorder which involves a preoccupation with certain aspects of physical appearance. Currently, there are no FDA approved medication treatments for Pediatric BDD. This is a collaborative study with Mount Sinai School of Medicine, Butler Hospital and Massachusetts General Hospital.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This study is designed to gather
information about mental health symptom profile, treatment
barriers, and treatment utilization among individuals
suffering from Body Dysmorphic Disorder by Proxy (BDD-BP).
By examining the etiology, symptomatic profile, and
prevalence of this disorder, this study will collect
preliminary data that can be used to help further future
research to develop better treatment options for individuals
with BDD by proxy.
To participate, please use this link:
https://www.surveymonkey.com/s/BDDBYPROXY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This study is examining which areas of the brain are involved in attention (the ability to think, reason, and remember) in OCD. We are trying to understand whether people with OCD use certain areas of the brain differently than control participants or individuals with other disorders (schizophrenia, autism spectrum disorders) when performing tests of attention that involve eye movements. Different scans will be used to take pictures of your brain (Magnetic Resonance Imaging [MRI]) and brain function (special high-speed functional MRI [fMRI; MEG and EEG]) during certain tasks. This study will also look at your genes to find out if there are relationships between genes and brain function.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
The purpose of this study is to develop and test the effectiveness of Cognitive-Behavioral Therapy (CBT) for children and adolescents suffering from Body Dysmorphic Disorder. CBT is the most effective psychological treatment for adults with BDD. Information we have so far suggests that CBT might prove effective in treating children and adolescents with BDD as well.
|
|
| |
| |
|
|
|
|
|
|
|
|
|
|
| |
This study seeks to examine potential underlying cultural and ethnic
factors in the manifestation of Obsessive-compulsive Disorder using a simple, easy to
use survey. This study aims to identify disparities in healthcare between different
ethnic, religious and socioeconomic backgrounds as well as different sexual orientations
and genders. Please use this link to participate: www.surveymonkey.com/BDDSurvey | |
| |
| |
|
|
|
|
|
|
|
|
|
|
|
In this research study we seek to investigate the
effectiveness of D-cycloserine as a memory booster for Exposure and
Response Prevention in the treatment of Body Dysmorphic Disorder.
D-cycloserine is an antibiotic that has been used in the treatment of
tuberculosis for over 20 years. Research so far demonstrates
D-cycloserine does increase the effectiveness of Exposure and Response
Prevention in the treatment of Obsessive Compulsive Disorder. We would
like to expand this research with D-cycloserine to see if it is effective
with body dysmorphic disorder. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|